Lucid Diagnostics
Lucid Diagnostics Partners With Front Line Mobile to Promote Esophageal Cancer Test
Working with the first responder medical care provider, Lucid is planning high-volume testing events among firefighters and other frontline workers with elevated risk.
Lucid Diagnostics' Esophageal Precancer Test Sales Spike in Q2
The firm's revenues, all from the EsoGuard DNA screening test, increased to $976,000 in Q2 compared to $159,000 in the same quarter last year.
Earnings Roundup: DermTech, Exagen, Lucid Diagnostics, Oncocyte
These genomics and molecular diagnostics firms posted their quarterly financial results this week.
In Brief This Week: Veracyte, C2i Genomics, Nabsys, Novacyt, Azenta, Parkinson's Foundation, More
News items for the week of Feb. 5, 2024.
People in the News at Lucid Diagnostics, Invitae, Genomenon, Telesis Bio
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Nov. 13, 2023.